BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37801907)

  • 21. Microbiome of Barrier Organs in Allergy: Who Runs the World? Germs!
    Schwierzeck V; Hülpüsch C; Reiger M
    Handb Exp Pharmacol; 2022; 268():53-65. PubMed ID: 34228203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal Barrier in Human Health and Disease.
    Di Tommaso N; Gasbarrini A; Ponziani FR
    Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Atopic eczema and microbiome].
    Reiger M; Schwierzeck V; Traidl-Hoffmann C
    Hautarzt; 2019 Jun; 70(6):407-415. PubMed ID: 31111169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The intestinal microbiota fuelling metabolic inflammation.
    Tilg H; Zmora N; Adolph TE; Elinav E
    Nat Rev Immunol; 2020 Jan; 20(1):40-54. PubMed ID: 31388093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outside-in hypothesis revisited: The role of microbial, epithelial, and immune interactions.
    Sugita K; Soyka MB; Wawrzyniak P; Rinaldi AO; Mitamura Y; Akdis M; Akdis CA
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):517-527. PubMed ID: 32454094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic-Induced Gut Microbiota Dysbiosis Damages the Intestinal Barrier, Increasing Food Allergy in Adult Mice.
    Zhang Q; Cheng L; Wang J; Hao M; Che H
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review.
    Zhao M; Chu J; Feng S; Guo C; Xue B; He K; Li L
    Biomed Pharmacother; 2023 Aug; 164():114985. PubMed ID: 37311282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gut microbiome alterations in allergic and inflammatory skin diseases - an update.
    Polkowska-Pruszyńska B; Gerkowicz A; Krasowska D
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):455-464. PubMed ID: 31520544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection.
    Zhang Y; Gan Y; Wang J; Feng Z; Zhong Z; Bao H; Xiong Q; Wang R
    mSystems; 2022 Aug; 7(4):e0028222. PubMed ID: 35699454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal microbiota and the immune system in metabolic diseases.
    Sittipo P; Lobionda S; Lee YK; Maynard CL
    J Microbiol; 2018 Mar; 56(3):154-162. PubMed ID: 29492872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial Dysbiosis Tunes the Immune Response Towards Allergic Disease Outcomes.
    Augustine T; Kumar M; Al Khodor S; van Panhuys N
    Clin Rev Allergy Immunol; 2023 Aug; 65(1):43-71. PubMed ID: 35648372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-immune crosstalk with the skin microbiota in homeostasis and atopic dermatitis - a mini review.
    Kobayashi T; Imanishi I
    Vet Dermatol; 2021 Dec; 32(6):533-e147. PubMed ID: 34378246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of altered human exposome on the skin and mucosal epithelial barrier integrity.
    Pat Y; Ogulur I; Yazici D; Mitamura Y; Cevhertas L; Küçükkase OC; Mesisser SS; Akdis M; Nadeau K; Akdis CA
    Tissue Barriers; 2023 Oct; 11(4):2133877. PubMed ID: 36262078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D and Microbiota: Is There a Link with Allergies?
    Murdaca G; Gerosa A; Paladin F; Petrocchi L; Banchero S; Gangemi S
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are gut dysbiosis, barrier disruption, and endotoxemia related to adipose tissue dysfunction in metabolic disorders? Overview of the mechanisms involved.
    Rosendo-Silva D; Viana S; Carvalho E; Reis F; Matafome P
    Intern Emerg Med; 2023 Aug; 18(5):1287-1302. PubMed ID: 37014495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    Ozaka S; Sonoda A; Ariki S; Minata M; Kamiyama N; Hidano S; Sachi N; Ito K; Kudo Y; Dewayani A; Chalalai T; Ozaki T; Soga Y; Fukuda C; Mizukami K; Ishizawa S; Nishiyama M; Fujitsuka N; Mogami S; Kubota K; Murakami K; Kobayashi T
    PLoS One; 2022; 17(6):e0269698. PubMed ID: 35704618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the epithelial barrier hypothesis the key to understanding the higher incidence and excess mortality during COVID-19 pandemic? The case of Northern Italy.
    Fiorito S; Soligo M; Gao Y; Ogulur I; Akdis CA; Bonini S
    Allergy; 2022 May; 77(5):1408-1417. PubMed ID: 35102595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and Immune System Interactions.
    Yoo JY; Groer M; Dutra SVO; Sarkar A; McSkimming DI
    Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33076307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.